Financial Advocates Investment Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,373
Closed -$311K 764
2025
Q1
$311K Buy
1,373
+38
+3% +$8.36K 0.02% 552
2024
Q4
$274K Sell
1,335
-184
-12% -$40.4K 0.02% 620
2024
Q3
$368K Sell
1,519
-44
-3% -$10.3K 0.02% 545
2024
Q2
$343K Sell
1,563
-50
-3% -$10.9K 0.02% 547
2024
Q1
$363K Sell
1,613
-22
-1% -$4.96K 0.02% 532
2023
Q4
$359K Buy
1,635
+25
+2% +$5.29K 0.02% 498
2023
Q3
$353K Sell
1,610
-30
-2% -$6.79K 0.03% 487
2023
Q2
$369K Sell
1,640
-15
-0.9% -$3K 0.03% 462
2023
Q1
$317K Sell
1,655
-58
-3% -$11.2K 0.02% 539
2022
Q4
$316K Buy
+1,713
New +$301K 0.02% 551
2022
Q3
Sell
-1,898
Closed -$391K 829
2022
Q2
$391K Buy
+1,898
New +$428K 0.03% 445

Other funds holding STE

Financial Advocates Investment Management's STE Position: Q2 2025 in Review

Financial Advocates Investment Management sold out of Steris (STE) in Q2 2025, closing a stake of 1,373 shares — an estimated $311K sold.

Financial Advocates Investment Management first reported a position in STE in Q2 2022 and held it in 11 quarters. The position peaked at $391K in Q2 2022. 836 funds tracked by Wall St. Rank hold STE as of Q2 2025.

  • Financial Advocates Investment Management reported no remaining Steris position as of Q2 2025 after selling out during the quarter.
  • Financial Advocates Investment Management sold 1,373 Steris shares in Q2 2025, an estimated $311K.
  • Financial Advocates Investment Management first reported a position in Steris in Q2 2022 and held it in 11 quarters.
  • Financial Advocates Investment Management's Steris position peaked at $391K in Q2 2022.
  • 836 funds tracked by Wall St. Rank held Steris as of Q2 2025.

Based on Financial Advocates Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.